Form 4: United Therapeutics CFO James Edgemond Executes Stock Transactions
SEC Form 4
James Edgemond, CFO and Treasurer of United Therapeutics Corp, reports the acquisition and disposal of common stock and share tracking awards on May 15, 2024.
Summary
- On May 15, 2024, James Edgemond, CFO and Treasurer of United Therapeutics Corp, engaged in transactions involving the company's common stock and share tracking awards.
- Edgemond acquired 25,000 shares of common stock at a price of $163.3 and disposed of 25,000 shares at $272.69.
- He also acquired 15,160 shares of common stock at $163.3 and disposed of 15,160 shares at $272.69.
- These transactions resulted in Edgemond holding 1,578 shares of common stock directly.
- Additionally, Edgemond exercised share tracking awards, which are non-dilutive cash-settled stock appreciation rights, for 25,000 and 15,160 shares, respectively, originally granted on March 13, 2016, and expiring on March 13, 2025.
- Following these transactions, Edgemond holds no share tracking awards.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options and awards to align management's interests with those of shareholders.
- The use of share tracking awards, which are cash-settled, is a less common but still utilized method of providing equity-linked compensation without diluting existing shareholders.
- Companies like Amgen and Gilead also use stock options as part of their compensation packages.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in beneficial ownership.
- The cash settlement of share tracking awards could affect the company's cash flow.
Key Dates
| Date | Description |
|---|---|
| 03/13/2016 | Original grant date of share tracking awards. |
| 09/02/2022 | Date of common stock acquisition under the Employee Stock Purchase Plan. |
| 03/03/2023 | Date of common stock acquisition under the Employee Stock Purchase Plan. |
| 09/01/2023 | Date of common stock acquisition under the Employee Stock Purchase Plan. |
| 03/04/2024 | Date of common stock acquisition under the Employee Stock Purchase Plan. |
| 03/13/2025 | Expiration date of share tracking awards. |
| 05/15/2024 | Date of stock and derivative transactions. |
| 05/16/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.